Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.

Clemens SAC, Folegatti PM, Emary KRW, Weckx LY, Ratcliff J, Bibi S, De Almeida Mendes AV, Milan EP, Pittella A, Schwarzbold AV, Sprinz E, Aley PK, Bonsall D, Fraser C, Fuskova M, Gilbert SC, Jenkin D, Kelly S, Kerridge S, Lambe T, Marchevsky NG, Mujadidi YF, Plested E, Ramasamy MN, Simmonds P, Golubchik T, Voysey M, Pollard AJ, AMPHEUS Project, Oxford COVID Vaccine Trial Team

Open source

DOI
10.1038/s41467-021-25982-w
Published
2021 Oct 6
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-021-25982-w,
  title = {Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.},
  author = {Clemens SAC and Folegatti PM and Emary KRW and Weckx LY and Ratcliff J and Bibi S and De Almeida Mendes AV and Milan EP and Pittella A and Schwarzbold AV and Sprinz E and Aley PK and Bonsall D and Fraser C and Fuskova M and Gilbert SC and Jenkin D and Kelly S and Kerridge S and Lambe T and Marchevsky NG and Mujadidi YF and Plested E and Ramasamy MN and Simmonds P and Golubchik T and Voysey M and Pollard AJ and AMPHEUS Project and Oxford COVID Vaccine Trial Team},
  year = {2021},
  journal = {Nature communications},
  doi = {10.1038/s41467-021-25982-w},
  url = {https://doi.org/10.1038/s41467-021-25982-w}
}

RIS

TY  - JOUR
TI  - Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
AU  - Clemens SAC
AU  - Folegatti PM
AU  - Emary KRW
AU  - Weckx LY
AU  - Ratcliff J
AU  - Bibi S
AU  - De Almeida Mendes AV
AU  - Milan EP
AU  - Pittella A
AU  - Schwarzbold AV
AU  - Sprinz E
AU  - Aley PK
AU  - Bonsall D
AU  - Fraser C
AU  - Fuskova M
AU  - Gilbert SC
AU  - Jenkin D
AU  - Kelly S
AU  - Kerridge S
AU  - Lambe T
AU  - Marchevsky NG
AU  - Mujadidi YF
AU  - Plested E
AU  - Ramasamy MN
AU  - Simmonds P
AU  - Golubchik T
AU  - Voysey M
AU  - Pollard AJ
AU  - AMPHEUS Project
AU  - Oxford COVID Vaccine Trial Team
PY  - 2021
JO  - Nature communications
DO  - 10.1038/s41467-021-25982-w
UR  - https://doi.org/10.1038/s41467-021-25982-w
ER  - 

APA

SAC, C., PM, F., KRW, E., LY, W., J, R., S, B., AV, D. A. M., EP, M., A, P., AV, S., E, S., PK, A., D, B., C, F., M, F., SC, G., D, J., S, K., S, K., T, L., NG, M., YF, M., E, P., MN, R., P, S., T, G., M, V., AJ, P., Project, A., & Team, O. C. V. T. (2021). Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.. Nature communications. https://doi.org/10.1038/s41467-021-25982-w

Source records